Education
About Us
Working with TipRanks
Follow Us
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
RESEARCH TOOLSreports
IDXG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.44 - $3.54
Previous CloseN/A
Volume34.00
Average Volume (3M)8.14K
Market Cap
$3.60M
Enterprise Value$5.97M
Total Cash (Recent Filing)$502.00K
Total Debt (Recent Filing)$3.15M
Price to Earnings (P/E)1.5
Beta1.35
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding4,423,093
10 Day Avg. Volume10,176
30 Day Avg. Volume8,142
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.66
Enterprise Value/Revenue0.13
Enterprise Value/Gross Profit0.21
Enterprise Value/Ebitda0.91
Forecast
1Y Price Target
$1.00Price Target Upside23.46% Upside
Rating ConsensusHold
Number of Analyst Covering0
Interpace Diagnostics Group News
IDXG FAQ
What was Interpace Diagnostics Group’s price range in the past 12 months?
Interpace Diagnostics Group lowest stock price was $0.44 and its highest was $3.54 in the past 12 months.
What is Interpace Diagnostics Group’s market cap?
Interpace Diagnostics Group’s market cap is $3.60M.
When is Interpace Diagnostics Group’s upcoming earnings report date?
Interpace Diagnostics Group’s upcoming earnings report date is Nov 05, 2025 which is in 56 days.
How were Interpace Diagnostics Group’s earnings last quarter?
Interpace Diagnostics Group released its earnings results on Aug 07, 2025. The company reported -$0.145 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.145.
Is Interpace Diagnostics Group overvalued?
According to Wall Street analysts Interpace Diagnostics Group’s price is currently Undervalued.
Does Interpace Diagnostics Group pay dividends?
Interpace Diagnostics Group does not currently pay dividends.
What is Interpace Diagnostics Group’s EPS estimate?
Interpace Diagnostics Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Interpace Diagnostics Group have?
Interpace Diagnostics Group has 4,423,093 shares outstanding.
What happened to Interpace Diagnostics Group’s price movement after its last earnings report?
Interpace Diagnostics Group reported an EPS of -$0.145 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.19%.
Which hedge fund is a major shareholder of Interpace Diagnostics Group?
Currently, no hedge funds are holding shares in IDXG
Company Description
Interpace Diagnostics Group
Interpace Diagnostics Group (IDXG) is a biotechnology company specializing in molecular diagnostics and genomic testing services. The company focuses on developing innovative diagnostic solutions aimed at improving patient outcomes in various areas, particularly in oncology and gastrointestinal diseases. IDXG's core products include its proprietary tests that help in the diagnosis and management of malignancies, providing healthcare providers with critical information to guide treatment decisions.
Technical Analysis
Check-Cap
―
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
Mainz Biomed B.V.
―
bioAffinity Technologies, Inc.
―
Ownership Overview
Options Prices
Currently, No data available
---